Briefs

S2K is a consortium of highly recognized researchers from across Canada funded by a $15 million grant from Genome Canada, Genome Quebec and Ontario Genomics Institute. The S2K program, which is hosted by the Universit� de Montr�al, aims to study the functional genomics, pharmacogenomics and proteomics of the immune response regarding HIV and HCV infections, SARS, transplant rejection and rheumatoid arthritis diseases. The ultimate goal of this program is to develop a bioinformatic model to predict susceptibility and progression of the targeted diseases as well as the response to a given therapy.

Predictive Patterns was chosen by the S2K team to deliver advanced data analysis software products and training that will be a key tool to better analyze and interpret their results and obtain the best biological understanding of their data.

"S2K team's choice of GeneLinker demonstrates their confidence in our continued ability to deliver high-quality software products." said Tom Radcliffe, Ph.D., P.Eng., founder and President of PPS.

For further information visit http://www.predictivepatterns.com/